8th German Pharm-Tox Summit

Prof. Dr.

Targeted investigation of prenyltransferase promoters shows no aberrant DNA methylation in cancer cells, but reveals evidence for differential, CpG-site-specific maximum proportion of DNA methylation independent of cell line, chromatin state and methylation mechanism.

Pharmacogenomics and personalized medicine	

Cancer pharmacology	

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session. </B>


Targeted investigation of prenyltransferase promoters shows no aberrant DNA methylation in cancer cells, but reveals evidence for differential, CpG-site-specific maximum proportion of DNA methylation independent of cell line, chromatin state and methylation mechanism.

Appointment

Session

Topics

Authors